An open label, block randomized, community study of the safety and efficacy of coadministered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic fila


The document is not on the server. This browser does not support external PDFs as inline view . Please download the PDF to view it: Download PDF